HERON THERAPEUTICS, INC. /DE/ (HRTX) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Heron Therapeutics, Inc. /De/ quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Heron Therapeutics, Inc. /De/ Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.91 B, a 4.43% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.91 B -$81 M -4.43% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1.91 B -$111 M -6.16% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$1.9 B -$120 M -6.74% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$1.87 B -$137 M -7.88% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$1.83 B -$151 M -9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$1.8 B -$182 M -11.3% Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$1.78 B -$217 M -13.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$1.73 B -$227 M -15.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$1.68 B -$232 M -16% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$1.61 B -$221 M -15.8% Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$1.56 B -$228 M -17.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 -$1.51 B -$234 M -18.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$1.45 B -$228 M -18.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 -$1.39 B -$227 M -19.5% Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$1.33 B -$223 M -20.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$1.27 B -$198 M -18.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$1.22 B -$193 M -18.9% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$1.17 B -$205 M -21.3% Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$1.11 B -$196 M -21.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$1.07 B -$201 M -23% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 -$1.02 B -$190 M -22.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$961 M -$177 M -22.6% Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$911 M -$190 M -26.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$873 M -$194 M -28.5% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$834 M -$198 M -31.1% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$783 M -$197 M -33.7% Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$721 M -$183 M -34% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 -$679 M -$190 M -38.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$636 M -$190 M -42.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$586 M -$173 M -41.9% Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$538 M -$156 M -41% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$489 M -$131 M -36.4% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 -$446 M -$110 M -32.9% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 -$413 M -$97.6 M -31% Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$382 M -$87 M -29.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$359 M -$83.5 M -30.3% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 -$336 M -$79.4 M -31% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 -$315 M -$76.4 M -32% Dec 31, 2014 10-K 2016-02-19
Q3 2014 -$295 M -$69.8 M -31% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 -$275 M -$63.5 M -29.9% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 -$256 M -$59.9 M -30.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 -$239 M -$55.3 M -30.1% Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$225 M -$49 M -27.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 -$212 M -$42.2 M -24.9% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 -$197 M -$31.4 M -19% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 -$184 M -$23.3 M -14.6% Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$176 M -$19.9 M -12.7% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 -$170 M -$18 M -11.8% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 -$165 M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 -$160 M -$11.8 M -7.96% Dec 31, 2011 10-K 2013-03-01
Q3 2011 -$156 M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 -$152 M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 -$148 M Dec 31, 2010 10-K 2012-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.